Gene hunt: canagliflozin response studied in amish volunteers
NCT ID NCT02891954
First seen Jan 11, 2026 · Last updated May 23, 2026 · Updated 23 times
Summary
This study gives healthy Amish volunteers a diabetes drug called canagliflozin for five days to see how their genes influence the drug's effects. Researchers measure urine sugar and other health markers to find genetic variants linked to drug response. The goal is to learn why people respond differently to SGLT2 inhibitors, not to treat any disease.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for DIABETES MELLITUS, TYPE 2 are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
Explore the condition pages connected to this study.